Showing results (161-170 of 352) with videos related to
Sort By:
Pageof 36
Journal of Neurochemistry|May 25, 2010
Interrelation of dopamine transporter oligomerization and surface presence as studied with mutant transporter proteins and amphetamineYan Li, Shu-Yuan Cheng, Nianhang Chen, et al.Journal of Neurochemistry|June 13, 2009
Interaction of catechol and non-catechol substrates with externally or internally facing dopamine transportersYing-Jian Liang, Juan Zhen, Nianhang Chen, et al.Bioorganic & Medicinal Chemistry|February 17, 2006
Design, synthesis, and preliminary SAR study of 3- and 6-side-chain-extended tetrahydro-pyran analogues of cis- and trans-(6-benzhydryl-tetrahydropyran-3-yl)-benzylamineShijun Zhang, Juan Zhen, Maarten E A Reith, et al.Journal of Medicinal Chemistry|July 22, 2005
Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific mannerShijun Zhang, Juan Zhen, Maarten E A Reith, et al.Journal of Neuroscience Methods|February 4, 2010
Concentration of receptor and ligand revisited in a modified receptor binding protocol for high-affinity radioligands: [3H]Spiperone binding to D2 and D3 dopamine receptorsJuan Zhen, Tamara Antonio, Aloke K Dutta, et al.European Journal of Pharmacology|June 20, 2008
D-161, a novel pyran-based triple monoamine transporter blocker: behavioral pharmacological evidence for antidepressant-like actionAloke K Dutta, Balaram Ghosh, Swati Biswas, et al.European Journal of Pharmacology|October 25, 2003
Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporterNianhang Chen, Michael Appell, Janet L Berfield, et al.Journal of Medicinal Chemistry|May 31, 2012
Structure-activity relationship study of N⁶-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N⁶-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterizationMark Johnson, Tamara Antonio, Maarten E A Reith, et al.The Journal of Biological Chemistry|December 9, 2003
Aspartate 345 of the dopamine transporter is critical for conformational changes in substrate translocation and cocaine bindingNianhang Chen, Judy Rickey, Janet L Berfield, et al.Biochimica Et Biophysica Acta|February 17, 1984
Inhibition by chloroquine of the secretion of very low density lipoproteins by cultured rat hepatocytesJ O Nossen, A C Rustan, T Barnard, et al.Pageof 36